<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2021.100200"><dct:format>application/xml</dct:format><dct:title>Therapeutic indication of Phloridzin: A new Gleam for metabolic disorders</dct:title><dct:creator>Sheema Khanam</dct:creator><dct:creator>Dr. Anuradha Mishra</dct:creator><dct:creator>Arshiya Shahid</dct:creator><dct:creator>Neelkanth Mani Pujari</dct:creator><dct:subject><rdf:Bag><rdf:li>Phloridzin</rdf:li><rdf:li>Phytochemical</rdf:li><rdf:li>Apple</rdf:li><rdf:li>Derivatives</rdf:li><rdf:li>Biological activity</rdf:li></rdf:Bag></dct:subject><dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2021.100200</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Phytomedicine Plus</prism:publicationName><prism:copyright>&#169; 2021 The Author(s). Published by Elsevier B.V.</prism:copyright><dct:publisher>Elsevier B.V.</dct:publisher><prism:issn>2667-0313</prism:issn><prism:volume>2</prism:volume><prism:number>1</prism:number><prism:coverDisplayDate>February 2022</prism:coverDisplayDate><prism:doi>10.1016/j.phyplu.2021.100200</prism:doi><prism:url>http://dx.doi.org/10.1016/j.phyplu.2021.100200</prism:url><dct:identifier>doi:10.1016/j.phyplu.2021.100200</dct:identifier><bam:articleNumber>100200</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-12-12T12:45:46Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="rev" version="5.6" xml:lang="en"><ja:item-info><ja:jid>PHYPLU</ja:jid><ja:aid>100200</ja:aid><ce:article-number>100200</ce:article-number><ce:pii>S2667-0313(21)00182-2</ce:pii><ce:doi>10.1016/j.phyplu.2021.100200</ce:doi><ce:copyright type="other" year="2021">The Author(s)</ce:copyright></ja:item-info><ja:head><ce:title id="tte0002">Therapeutic indication of Phloridzin: A new Gleam for metabolic disorders</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2667031321001822-971c147542b214cee87f008ebe7779a6"><ce:given-name>Sheema</ce:given-name><ce:surname>Khanam</ce:surname></ce:author><ce:author id="au0002" author-id="S2667031321001822-a6d1a1b5cb7afb3982b15587b6c10fa6"><ce:given-name>Dr. Anuradha</ce:given-name><ce:surname>Mishra</ce:surname><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:misra.anuradha@gmail.com">misra.anuradha@gmail.com</ce:e-address></ce:author><ce:author id="au0003" author-id="S2667031321001822-8bd66fe6c88870a5c6f4ff698caea099"><ce:given-name>Arshiya</ce:given-name><ce:surname>Shahid</ce:surname></ce:author><ce:author id="au0004" author-id="S2667031321001822-b56f59bdd835ca4108f82914a551b782"><ce:given-name>Neelkanth Mani</ce:given-name><ce:surname>Pujari</ce:surname></ce:author><ce:affiliation id="aff0001" affiliation-id="S2667031321001822-5b2e9976f4f70a52517a636cf4f4523a"><ce:textfn id="cetextfn0001">Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, 226026, Uttar Pradesh, India</ce:textfn><sa:affiliation><sa:organization>Faculty of Pharmacy</sa:organization><sa:organization>Integral University</sa:organization><sa:address-line>Dasauli, Kursi Road</sa:address-line><sa:city>Lucknow</sa:city><sa:state>Uttar Pradesh</sa:state><sa:postal-code>226026</sa:postal-code><sa:country>India</sa:country></sa:affiliation><ce:source-text id="staff0001">Faculty of Pharmacy, Integral University, Dasauli, Kursi Road, Lucknow, 226026, Uttar Pradesh, India</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding Author: Associate Professor, Department of Pharmacology, Faculty of Pharmacy, Integral University, Kursi Road Lucknow, 226026 (U.P.) India, Tel Number: +91-7376550091</ce:text><sa:affiliation><sa:organization>Associate Professor, Department of Pharmacology, Faculty of Pharmacy</sa:organization><sa:organization>Integral University</sa:organization><sa:address-line>Kursi Road</sa:address-line><sa:city>Lucknow</sa:city><sa:postal-code>226026</sa:postal-code><sa:country>(U.P.) India</sa:country></sa:affiliation></ce:correspondence></ce:author-group><ce:abstract id="abs0001" class="author-highlights" view="all"><ce:section-title id="cesectitle0001">Highlights</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara007" view="all"><ce:list id="celist0001"><ce:list-item id="celistitem0001"><ce:label>&#x2022;</ce:label><ce:para id="para0001" view="all"><ce:italic>Phloridizin</ce:italic> Pharmacokinetics and therapeutic applications.</ce:para></ce:list-item><ce:list-item id="celistitem0002"><ce:label>&#x2022;</ce:label><ce:para id="para0002" view="all">Phloridizin <ce:italic>In vitro</ce:italic> and <ce:italic>In vivo</ce:italic> study reports.</ce:para></ce:list-item><ce:list-item id="celistitem0003"><ce:label>&#x2022;</ce:label><ce:para id="para0003" view="all">Available Patents on Phloridizin</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0002" view="all" class="author"><ce:section-title id="cesectitle0002">Abstract</ce:section-title><ce:abstract-sec id="abss0003" role="background" view="all"><ce:section-title id="cesectitle0003">Background</ce:section-title><ce:simple-para id="spara008" view="all">Phloridizin is a phenolic phytoconstituent and a glucoside derivative of Phloretin, which is a Dihydrochalcone, belonging to the family of bicyclic flavonoids. It was first isolated from the bark of the apple tree. Phloridzin (PZ or phloretin-2&#x2032;-O-glucoside) is an important derivative of flavonoid glycoside, mainly found in <ce:cross-out>the</ce:cross-out> apple peels.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0004" role="materials-methods" view="all"><ce:section-title id="cesectitle0004">Method</ce:section-title><ce:simple-para id="spara009" view="all">Literature was collected from 1988 to 2021 out of which containing 348 articles 313 for the next 10 years and 424 and more than 800 from 2000 onwards to till 2021, the studies were conducted on various aspects including agricultural, nutritional supplements, preclinical and clinical findings on Phloridizin.The Figure represented detailed literature collected from Pub med central.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0005" role="results" view="all"><ce:section-title id="cesectitle0005">Results</ce:section-title><ce:simple-para id="spara010" view="all">It covers <ce:cross-out>about</ce:cross-out> the efficient sources of Phloridzin. This review confers <ce:cross-out>about</ce:cross-out> the preclinical and clinical application of Phloridizin in metabolic disorders.</ce:simple-para></ce:abstract-sec><ce:abstract-sec id="abss0006" role="conclusion" view="all"><ce:section-title id="cesectitle0006">Conclusion</ce:section-title><ce:simple-para id="spara011" view="all">It summarizes <ce:cross-out>about</ce:cross-out> the therapeutic application of Phloridizin along with approaches to overcome its limitations for better clinical application.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract id="abs0003" class="graphical" view="all"><ce:section-title id="cesectitle0007">Graphical abstract</ce:section-title><ce:abstract-sec id="abss0007" view="all"><ce:simple-para id="spara012" view="all"> [Display omitted] </ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0008">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Phloridzin</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Phytochemical</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Apple</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Derivatives</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Biological activity</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
